These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1559752

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P, Connelly MC, Srinivas RV, Fridland A.
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [Abstract] [Full Text] [Related]

  • 23. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Gordon YJ, Romanowski EG, Araullo-Cruz T.
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
    [Abstract] [Full Text] [Related]

  • 24. Ocular toxicity of multiple intravitreal DHPG injections.
    Yoshizumi MO, Lee D, Vinci V, Fajardo S.
    Graefes Arch Clin Exp Ophthalmol; 1990 Nov; 228(4):350-5. PubMed ID: 2401420
    [Abstract] [Full Text] [Related]

  • 25. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB, Yang ZH, Feng JS, Fong CK, Lucia HL, Hsiung GD.
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery.
    Cheng L, Hostetler KY, Gardner MF, Avila CP, Bergeron-Lynn G, Keefe KS, Beadle JR, Wiley CA, Freeman WR.
    J Ocul Pharmacol Ther; 1999 Aug; 15(4):363-77. PubMed ID: 10463875
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E, Del Sole MJ, Torbidoni A, Fandino A, Asprea M, Croxatto JO, Chantada GL, Bramuglia GF, Schaiquevich P.
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [Abstract] [Full Text] [Related]

  • 31. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F, Ramazzotti M, Vannozzi L, Rapizzi E, Fiore T, Iaccheri B, Degl' Innocenti D, Moncini D, Menchini U.
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N, Hitchcock MJ, Chen MS, Barkhimer DB, Cundy KC, Kent KM, Lacy SA, Lee WA, Li ZH, Mendel DB.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [Abstract] [Full Text] [Related]

  • 35. [Antiviral effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine on adenovirus].
    Nakajima H, Goto M, Shimada Y, Nagamoto Y, Ishiko H, Inagawa W, Itoh N, Uchio E, Ohno S, Aoki K.
    Nippon Ganka Gakkai Zasshi; 2000 Feb; 104(2):77-81. PubMed ID: 10714154
    [Abstract] [Full Text] [Related]

  • 36. Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis.
    Taskintuna I, Rahhal FM, Capparelli EV, Cundy KC, Freeman WR.
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):147-51. PubMed ID: 9572540
    [Abstract] [Full Text] [Related]

  • 37. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
    Cheng L, Hostetler KY, Gardner MF, Avila CP, Bergeron-Lynn G, Keefe KS, Wiley CA, Freeman WR.
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
    [Abstract] [Full Text] [Related]

  • 38. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
    López-Cortés LF, Pastor-Ramos MT, Ruiz-Valderas R, Cordero E, Uceda-Montañés A, Claro-Cala CM, Lucero-Muñoz MJ.
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
    [Abstract] [Full Text] [Related]

  • 39. Retinal toxicity of intravitreally injected faeriefungin.
    Dunlap WA, Karaçorlu M, Peyman GA, Nair MG, Rahimy M, Pedroza L.
    Ophthalmic Surg; 1994 May; 25(5):303-6. PubMed ID: 8058262
    [Abstract] [Full Text] [Related]

  • 40. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y, Zemel E, Miller B, Perlman I.
    Retina; 2007 May; 27(6):778-88. PubMed ID: 17621190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.